Trade Summary

3 days ago, Cross Shawn, serving as CFO at Pacira Biosciences, Inc. (PCRX), sold 12,059 shares at $25.09 per share, for a total transaction value of $302,598.00. Following this transaction, Cross Shawn now holds 105,341 shares of PCRX.

This sale represents a 10.00% decrease in Cross Shawn's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 2 days after the trade was made.

Pacira Biosciences, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.